|
Evelo Biosciences, Inc.
Ticker Symbol: EVLO CUSIP: 299734202 Previous CUSIP: 299734103 Exchange: NGS
Company's Online Profile
BUSINESS: Evelo Biosciences, Inc. is dedicated to improving the lives of patients globally through the development of a new modality of medicines monoclonal microbials. Evelo's monoclonal microbial product candidates are orally delivered and are intended to modulate systemic immunology and biology through direct interactions with human cells in the gut.
|
IPO - 5/9/2018 - 5.31 Million Shares @ $16.00/share.
Link to IPO Prospectus
Mid Cap Stock -
Market Value $ Million
Click for current EVLO price quote from the NASDAQ
Yahoo News Summary for EVLO
YAHOO! Profile for EVLO
Yahoo Detailed Quote
MarketWatch Quote
MSN Company Report for EVLO
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 620 Memorial Drive, Suite 200, Cambridge, MA 02139 |
| Main Phone Number |
617-577-0300 |
| Fax Number |
Not Available |
| Investor Contact
Stefan Riley
|
617-704-2333
|
| CEO - Simba Gill |
CFO - Luca Scavo |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
